AVBPArriVent BioPharma, Inc.

$16.72-5.3% 1Y

Is the price fair?

What AVBP's price assumes

Price / book
4.39

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
4.39
Market capitalisation
$1.58B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks